… on published clinical trials and retrospective observational studies for the therapeutic options
of … papers to summarize some evidence-based therapeutic options for COVID-19 infection. …

… evidence of potential therapeutic options for COVID-19, including antivirals, anti-inflammatories,
convalescent plasma therapy, monoclonal antibodies, immunoglobulin therapy, cell …

… [ 11 ] Oseltamivir was also used in the management of 2019-nCoV; however, definite
evidence of efficacy is inconclusive because of lack of suitable control group in the studies.[ 12 ] …

… Recent clinical evidence substantiating the efficacy and safety of incretin-based antidiabetic
therapies is analysed, in addition to data on antiobesity therapeutic strategies, such as …

… Therapeutic options are limited owing to high levels of resistance of the organism, either …
We systematically searched for relevant publications including clinical data in PubMed and …

… For many years the only therapeutic options for type 2 DM were sulfonylureas and insulin. …
on dual therapy begin insulin or start a third oral agent? If insulin therapy is started, what …

… access and is under extensive clinical investigation. Hereafter, this review aims to
address the viral polymerase inhibitor remdesivir as a potential therapeutic option for COVID-19. …

Therapeutic decision‐making in Huntington's disease (HD) is often guided by clinical
experience, because of the limited empirical evidence available. The only medication for HD that …

… therapy, drugs which are currently being tested in clinical trials. In this paper, we review the
evidence … treated with ERT including all clinical trials published and observational studies …

… In this review we will focus on the current pharmacological options available in AD treatment:
… In the last section we will briefly summarize new therapeutic approaches for AD such anti…